Peptide vaccines have been improved by the inclusion ... cells when invaded by a specific pathogen or when a cell becomes a cancer cell. The T-cell receptor identifies antigens that are presented ...

Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...

Tumor-associated carbohydrate (TAC) antigens are prime candidates for cancer vaccines because of their ... 660) have overcome this obstacle by designing a peptide that mimics a TAC antigen.

A National Cancer Institute (NCI)-funded (CA84356 ... The trial consisted of four cohorts with increasing doses of peptide vaccines ranging from 0.5 to 3.0 mg. Eligible patients received three ...

a dual-targeted immunotherapy combining antigenic peptides for both the survivin and MAGE-A9 cancer proteins to elicit immune responses to these two distinct cancer antigens simultaneously, DPX™-RSV ...

An enormous amount of data indicate that current cancer treatment is greatly hampered by toxicity and serious adverse effects. Most of this is as a result of the nonspecificity of existing agents ...

CNW/ -- (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at the Personalized ...

Abstract Number: SESS-1071 (Spotlight Poster) Title: Overall survival results of Bria-IMT™ allogenic whole cell-based cancer vaccine Time: Wednesday, December 11, 2024 7:00 AM – 8:30 AM CST ...

Antimicrobial peptides derived from a crab and a spider may provide the pathway to overcoming drug resistance in advanced ...